HomeABVC • NASDAQ
add
ABVC Biopharma Inc
Previous close
$0.55
Day range
$0.53 - $0.57
Year range
$0.41 - $2.45
Market cap
7.12M USD
Avg Volume
242.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 389.28K | 2,350.74% |
Operating expense | 322.17K | -84.95% |
Net income | -186.56K | 94.38% |
Net profit margin | -47.93 | 99.77% |
Earnings per share | — | — |
EBITDA | 73.82K | 103.44% |
Effective tax rate | -0.27% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 208.15K | -63.39% |
Total assets | 14.46M | -12.83% |
Total liabilities | 6.48M | -13.90% |
Total equity | 7.98M | — |
Shares outstanding | 12.41M | — |
Price to book | 0.82 | — |
Return on assets | 1.15% | — |
Return on capital | 1.60% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -186.56K | 94.38% |
Cash from operations | 171.72K | 112.64% |
Cash from investing | — | — |
Cash from financing | -145.39K | -108.78% |
Net change in cash | 27.10K | -92.84% |
Free cash flow | 47.89K | 103.25% |
About
Founded
2015
Website
Employees
18